Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Epoxide hydrolases (EHs) are enzymes that catalyze the hydrolysis of epoxides into diols. They play a critical role in detoxification, metabolism of endogenous lipid mediators, and regulation of various signaling pathways. Several isoforms exist, including microsomal EH (mEH/EPHX1), soluble EH (sEH/EPHX2), and EPHX3/EHPX4, each with distinct tissue distribution and substrate preferences. sEH, in particular, is a therapeutic target for cardiovascular and inflammatory diseases due to its role in regulating bioactive lipids like EETs. The catalytic mechanism involves a two-step process with nucleophilic attack and water-mediated ester hydrolysis. Dysregulation of EHs is associated with various diseases, making them attractive therapeutic targets.
Inhibition of epoxide hydrolysis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Epoxide Hydrolase.